Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care

Схожие документы

• Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care
  по: Cynthia Sung, et al.
  Опубликовано: (2020-05-01)
• HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
  по: Nguyen, Dinh Van, et al.
  Опубликовано: (2015)
• Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
  по: Simper, Gwendolin S., et al.
  Опубликовано: (2018)
• AB086. HLA-B*1502 and HLA-B*5801 genotyping for the prevention of severe cutaneous adverse drug reactions in a Children’s Hospital
  по: Ching, Leng Kee, et al.
  Опубликовано: (2017)
• A Screening Test for HLA-B(∗)15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
  по: Fang, Hua, et al.
  Опубликовано: (2019)